Form D · Biotechnology
X-Biomedical Inc.
Wayne, PA · CIK 0001746921
Offering snapshot reported Jul 24, 2018 · SEC filing
- Reported sold
- $425K Offering amount: $1.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 11, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2018 | Initial | $425,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-317607
Source: Form D, filed Jul 24, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Maltese | Director |
| Karen Keating Mara | Executive |
| Godfrey Nazareth | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
435 Devon Park Drive 700 Building
Wayne, PA, 19087
Wayne, PA, 19087